Author

Sara G. I. Suliman

Observed names: S. G. I. Suliman, Sara G I Suliman, Sara G.I. Suliman, Sara GI Suliman

Institutions: Imperial College London Diabetes Centre, Imperial College London

Observed institutions: Churchill Hospital, University of Oxford, Imperial College London Diabetes Centre, Oxford Centre for Diabetes, Endocrinology and Metabolism, Imperial College London

ORCID: 0009-0002-4467-8799

Observed ORCID: 0009-0002-4467-8799

OpenAlex ID: A5103562831

Nonsurgical Cerebrospinal Fluid Rhinorrhea in Invasive Macroprolactinoma: Incidence, Radiological, and Clinicopathological Features

2007 · S. G. I. Suliman, A. Gurlek, et al. · The Journal of Clinical Endocrinology & Metabolism · 81

Early worsening of diabetic retinopathy in individuals with type 2 diabetes treated with tirzepatide: a real-world cohort study

2025 · Adam J. Buckley, Garry D. Tan, et al. · Diabetologia · 38

Severe Insulin Resistance and Intrauterine Growth Deficiency Associated With Haploinsufficiency for INSR and CHN2

2009 · Sara G.I. Suliman, Juraj Stanik, et al. · Diabetes · 26

EASO Position Statement: Women with Obesity across the Reproductive Life – Fertility, Preconception, Pregnancy, Postpartum, and Breastfeeding

2025 · Francesca Filippi-Arriaga, Nidhi Agarwal, et al. · Obesity Facts · 12

Post-bariatric Hypoglycemia Management: A Gulf Cooperation Council Consensus Statement

2025 · Elamin Abdelgadir, Fauzia Rashid, et al. · Journal of the Endocrine Society · 3

Preconception, pregnancy, and postnatal use of GLP-1 receptor agonist-based therapies in women with type 1, type 2, or gestational diabetes: a systematic review, meta-analysis, and international expert consensus statement

2026 · Sarah Dib, Matthew J Savage, et al. · The Lancet Obstetrics Gynaecology & Women s Health · 1

Toward “Obesityomics”: Domain‐Specific Omics in Precision Obesity Medicine with a Brief AI Perspective

2026 · Nadia Abu Samra, Sara G. I. Suliman, et al. · Obesity Reviews

Obesity medications in women's health: is metabolic bariatric surgery still relevant?

2026 · Sara G I Suliman, Ali Aminian, et al. · The Lancet Obstetrics Gynaecology & Women s Health

Global barriers to GLP-1 receptor agonist treatment in women: access, safety, and equity

2026 · Claire L Meek, Ranjit Mohan Anjana, et al. · The Lancet Obstetrics Gynaecology & Women s Health

Healthcare Provider Awareness and Perspectives on Obesity: A Survey Across Medical Specialties

2026 · Fatheya Alawadi, Rahila Bhatti, et al. · Obesity Science & Practice

Data-Driven Decision Support in Obesity Management Commission: enabling more equitable and personalized obesity care

2026 · Paul W. Franks, Sara G. I. Suliman, et al. · Nature Medicine

Integrating lifespan biology into obesity science

2026 · Sara G. I. Suliman, Jennifer L. Sargent · Metabologia

Emirates Diabetes and Endocrine Society Consensus for the Management of Type 2 Diabetes Mellitus (2026 Update)

2026 · Fatheya Al Awadi, Elamin Abdelgadir, et al. · Dubai Diabetes and Endocrinology Journal

No evidence that tirzepatide can worsen diabetic retinopathy. Reply to Fadini GP [letter]. Reassessing retinopathy risk with tirzepatide therapy. Reply to Zhang N, Wang W, Wan G [letter]

2025 · Adam J. Buckley, Garry D. Tan, et al. · Diabetologia

The short-term effect of surgical and pharmacological intervention in obesity caused by MC4R deficiency: A single centre experience

2021 · Saradalekshmi Koramannil Radha, Esphie Grace Fojas, et al. · Endocrine Abstracts

Works count: 16

Citation count: 162

H-index: 4

I10-index: 4